BROMONT, Québec, April 28, 2021 (GLOBE NEWSWIRE) - Boréas Technologies today announced the Boréas Piezo Haptic Engine (Boréas PHE), the first module to harness...
AstraZeneca's diabetes drug Farxiga stormed the heart failure market with a world-class approval last year - and in chronic kidney disease it left potential...
The results of the SURPASS-2 clinical trial evaluating the effects of tirzepatide in patients with type 2 diabetes showed that the trial treatment resulted...